GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » BL Pharmtech Corp (XKRX:065170) » Definitions » Enterprise Value

BL Pharmtech (XKRX:065170) Enterprise Value : ₩34,916 Mil (As of Apr. 26, 2024)


View and export this data going back to 2002. Start your Free Trial

What is BL Pharmtech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BL Pharmtech's Enterprise Value is ₩34,916 Mil. BL Pharmtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-12,284 Mil. Therefore, BL Pharmtech's EV-to-EBIT ratio for today is -2.84.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BL Pharmtech's Enterprise Value is ₩34,916 Mil. BL Pharmtech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-9,341 Mil. Therefore, BL Pharmtech's EV-to-EBITDA ratio for today is -3.74.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BL Pharmtech's Enterprise Value is ₩34,916 Mil. BL Pharmtech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩24,525 Mil. Therefore, BL Pharmtech's EV-to-Revenue ratio for today is 1.42.


BL Pharmtech Enterprise Value Historical Data

The historical data trend for BL Pharmtech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BL Pharmtech Enterprise Value Chart

BL Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94,325.03 184,097.18 142,703.97 100,069.49 36,364.18

BL Pharmtech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100,069.49 90,520.63 105,912.32 97,728.59 36,364.18

Competitive Comparison of BL Pharmtech's Enterprise Value

For the Food Distribution subindustry, BL Pharmtech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BL Pharmtech's Enterprise Value Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, BL Pharmtech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BL Pharmtech's Enterprise Value falls into.



BL Pharmtech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BL Pharmtech's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

BL Pharmtech's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BL Pharmtech  (XKRX:065170) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BL Pharmtech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=34916.177/-12283.864
=-2.84

BL Pharmtech's current Enterprise Value is ₩34,916 Mil.
BL Pharmtech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-12,284 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BL Pharmtech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=34916.177/-9340.699
=-3.74

BL Pharmtech's current Enterprise Value is ₩34,916 Mil.
BL Pharmtech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-9,341 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BL Pharmtech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=34916.177/24525.173
=1.42

BL Pharmtech's current Enterprise Value is ₩34,916 Mil.
BL Pharmtech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩24,525 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BL Pharmtech Enterprise Value Related Terms

Thank you for viewing the detailed overview of BL Pharmtech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BL Pharmtech (XKRX:065170) Business Description

Traded in Other Exchanges
N/A
Address
193-12 Daeyang-ro, Samseong-myeon, Eumseong-gun, Chungbuk, KOR, 138-200
BL Pharmtech Corp is engaged in the distribution and sale of healthy functional foods.

BL Pharmtech (XKRX:065170) Headlines

No Headlines